Inventor · disambiguated record
Larry Zeitlin
Also filed as: ZEITLIN LARRY
8 granted patents·5 pending applications·6 citations·filing 2012–2022
81Inventor score
Top patents by PatentIndex Score
13 records- 0184US11407817B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Aug 9, 2022·1 cites·18 claims
- 0284US11407816B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Aug 9, 2022·1 cites·18 claims
- 0384US11254732B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Feb 22, 2022·1 cites·9 claims
- 0484US11242379B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Feb 8, 2022·1 cites·9 claims
- 0584US11242378B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Feb 8, 2022·1 cites·9 claims
- 0681US12209117B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2022·Granted Jan 28, 2025·0 cites·18 claims
- 0766US10836810B2Monoclonal antibodies and cocktails for treatment of ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2018·Granted Nov 17, 2020·0 cites·9 claims
- 0863US10214747B2Method of purifying monoclonal antibodiesKENTUCKY BIOPROCESSING INC·Filed 2014·Granted Feb 26, 2019·1 cites·10 claims
- 0954US2019263894A1Monoclonal antibody cocktails for treatment of ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 1052US2019247501A1Monoclonal antibody cocktails for treatment of ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 1146US2016326234A1Monoclonal antibody cocktails for treatment of ebola infectionsHIATT ANDREW·Filed 2016·Application pending·0 cites
- 1244US2016324965A1Monoclonal antibody cocktails for treatment of ebola infectionsHIATT ANDREW·Filed 2015·Application pending·0 cites
- 1342US2013149300A1MONOCLONAL ANTIBODIES WITH ALTERED AFFINITIES FOR HUMAN FCyRI, FCyRIIIa, AND C1q PROTEINSMAPP BIOPHARMACEUTICAL INC·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →